Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines

Cagri Gulec1, Neslihan Coban1, Bilge Ozsait-Selcuk1

  • 1Istanbul University, Institute for Experimental Medicine, Department of Genetics, Vakif Gureba C. Capa-Fatih, 34104 Istanbul, Turkey.

Experimental Cell Research
|February 28, 2017
PubMed

Insights

This study identifies Retinoid-related Orphan Receptor alpha (ROR-alpha) target genes in monocytic and endothelial cells, revealing its role in regulating signaling and transport pathways, potentially impacting atherosclerosis treatment.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cardiovascular Research

Background:

  • Retinoid-related Orphan Receptor alpha (ROR-alpha) is a nuclear receptor implicated in atherosclerosis.
  • ROR-alpha activity can be modulated by various ligands, suggesting therapeutic potential.

Purpose of the Study:

  • To identify ROR-alpha target genes in monocytic (THP1) and endothelial (HUVEC) cell lines.
  • To investigate the role of ROR-alpha in cellular processes relevant to atherosclerosis.

Main Methods:

  • Chromatin immunoprecipitation followed by tiling array (ChIP-on-chip) was performed for ROR-alpha.
  • Bioinformatic analysis identified ROR-alpha binding sites.
  • Gene expression analysis validated direct and potential target genes.

Main Results:

  • ROR-alpha was found to bind near the transcription start site of over 3000 genes in both cell types.
  • Potential target genes are involved in membrane receptor activity, signal transduction, and ion transport.
  • SPP1 and IKBKA were identified as direct ROR-alpha targets in THP1 cells; HMOX1 and HSPA8 as potential targets.

Conclusions:

  • ROR-alpha regulates signaling receptor activity and transmembrane transport.
  • ROR-alpha influences cellular sensitivity to environmental substances.
  • Ligand-dependent modulation of ROR-alpha target genes warrants further investigation for therapeutic applications in atherosclerosis.

Related Concept Videos